Explore 10 brokerage-backed ‘Buy’ stocks, from NTPC to Eternal, with projected upsides of 13% to 55% across key sectors.
Track Hindustan Copper as the govt opens a 6% OFS at Rs 514/share, a 10.5% discount, aiming to raise nearly…
Brokerages see 10–43% upside in 10 Buy-rated stocks across defence, fintech, autos and consumer sectors; review targets before investing.
Emkay sees Siemens outperforming on a Rs 46,670-cr backlog and strong orders despite cost-hit margins; check the key growth drivers.
AI data centres are opening a fresh growth runway for Indian EMS companies, but Emkay sees a clear divide between…
Indus Towers faces Jio renewal risk but brokers see upside on Vodafone capex and cash flows; watch fundraise and tenancy…
Brokerages flag 10 Buy-rated stocks with projected upsides of 7%–69% across sectors as markets slip; see which names made the…
Nomura, Emkay lift IndusInd Bank targets after Q1 on cost control, asset quality and FY27 ROA hopes; check upside and…
SBI AMC lists at a 7% premium as Emkay and Equirus cite scale, distribution and 18-31% upside; review targets before…
JSW Steel gains after Q1 beat as Emkay, Motilal see project ramp-ups driving 13-19% upside; track the stock’s next move.
Brokerages see 13%-29% upside in 10 Buy-rated stocks across realty, telecom, IT and metals; review the top picks before you…
Adani Ports wins broker backing after MSC’s $1.4B Vizhinjam deal, with targets up to Rs 2,050; see what it means…
India’s textile exporters are set to gain after years of underperformance. Read on to know why brokerages see 45% profit…
Emkay Global sees 33% upside for SOBHA, citing robust launches and strong pre-sales—consider buying now for potential gains!
Emkay Global’s latest strategy report reveals Indian corporates wrapped up FY26 on a strong note, with mid-cap earnings skyrocketing by…
Emkay Global sees 21% upside for IPCA Labs, fueled by strong earnings and sales growth. Discover why analysts rate it…
Emkay ups Aditya Birla Fashion target to Rs 75 after strong Q4 growth and margin gains—see key drivers for stock…
Max Healthcare posts 3% net profit growth and aggressive expansion; discover why Emkay sees 10% upside—read more now!